Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 4 minute read Pharma Industry News Novo Nordisk stock rises on Wegovy STEER data: Can semaglutide cement its lead over Eli Lilly? Novo Nordisk shares gained after STEER study showed Wegovy cut heart risks by 57% over tirzepatide. Find out why semaglutide may lead the GLP-1 race. byPallavi MadhirajuSeptember 1, 2025